Mechanisms in endocrinology: Beyond the fixed setpoint of the hypothalamus-pituitary-thyroid axis

European Journal of Endocrinology

Volumn 171, Issue 5, 2014, Pages R197-R208

  Fliers, Eric ^a   Kalsbeek, Andries ^a,b   Boelen, Anita ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROTROPIN;

ADENOHYPOPHYSIS; ARTICLE; CIRCADIAN RHYTHM; CRITICAL ILLNESS; ENVIRONMENTAL FACTOR; FOOD AVAILABILITY; FOOD DEPRIVATION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; INFLAMMATION; MOLECULAR PATHOLOGY; NEGATIVE FEEDBACK; NERVE TRACT; NEUROENDOCRINE SYSTEM; NONHUMAN; SEPSIS; THYROID GLAND; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE METABOLISM; TISSUE LEVEL; ANIMAL; COMPLICATION; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CRITICAL ILLNESS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; NEURONS; PITUITARY GLAND; SEPSIS; THYROID GLAND; THYROID HORMONES; THYROTROPIN;

EID: 84910152444     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0285     Document Type: Article

References (88)

1. Segerson TP, Kauer J, Wolfe HC, Mobtaker H, Wu P, Jackson IM & Lechan RM. Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science 1987 238 78-80. (doi:10.1126/science.3116669)
2. Lechan RM & Fekete C. The TRH neuron: a hypothalamic integrator of energy metabolism. Progress in Brain Research 2006 153 209-235.
3. Dietrich JW, Landgrafe G & Fotiadou EH. TSH and thyrotropic agonists: key actors in thyroid homeostasis. Journal of Thyroid Research 2012 2012 351864. (doi:10.1155/2012/351864)
4. Hansen PS, Brix TH, Sorensen TI, Kyvik KO & Hegedüs L. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. Journal of Clinical Endocrinology and Metabolism 2004 89 1181-1187. (doi:10.1210/jc.2003-031641)
5. Panicker V, Wilson SG, Spector TD, Brown SJ, Kato BS, Reed PW, Falchi M, Richards JB, Surdulescu GL, Lim EM et al. Genetic loci linked to pituitary-thyroid axis set points: a genome-wide scan of a large twin cohort. Journal of Clinical Endocrinology and Metabolism 2008 93 3519-3523. (doi:10.1210/jc.2007-2650)
6. Roelfsema F & Veldhuis JD. Thyrotropin secretion patterns in health and disease. Endocrine Reviews 2013 34 619-657. (doi:10.1210/er.2012-1076)
7. Chan JL, Heist K, Depaoli AM, Veldhuis JD & Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. Journal of Clinical Investigation 2003 111 1409-1421. (doi:10.1172/JCI200317490)
8. Mebis L & Van den Berghe G. Thyroid axis function and dysfunction in critical illness. Best Practice & Research. Clinical Endocrinology & Metabolism 2011 25 745-757. (doi:10.1016/j.beem.2011.03.002)
9. Fliers E, Noppen NW, Wiersinga WM, Visser TJ & Swaab DF. Distribution of thyrotropin-releasing hormone (TRH)-containing cells and fibers in the human hypothalamus. Journal of Comparative Neurology 1994 350 311-323. (doi:10.1002/cne.903500213)
10. Guldenaar SE, Veldkamp B, Bakker O, Wiersinga WM, Swaab DF & Fliers E. Thyrotropin-releasing hormone gene expression in the human hypothalamus. Brain Research 1996 743 93-101. (doi:10.1016/S0006-8993(96)01024-4)
11. Abel ED, Ahima RS, Boers ME, Elmquist JK & Wondisford FE. Critical role for thyroid hormone receptor b2 in the regulation of paraventricular thyrotropin-releasing hormone neurons. Journal of Clinical Investigation 2001 107 1017-1023. (doi:10.1172/JCI10858)
12. Lechan RM, Qi Y, Jackson IM & Mahdavi V. Identification of thyroid hormone receptor isoforms in thyrotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Endocrinology 1994 135 92-100.
13. Alkemade A, Vuijst CL, Unmehopa UA, Bakker O, Vennstrom B, Wiersinga WM, Swaab DF & Fliers E. Thyroid hormone receptor expression in the human hypothalamus and anterior pituitary. Journal of Clinical Endocrinology and Metabolism 2005 90 904-912. (doi:10.1210/jc.2004-0474)
14. Heuer H & Visser TJ. Minireview: Pathophysiological importance of thyroid hormone transporters. Endocrinology 2009 150 1078-1083. (doi:10.1210/en.2008-1518)
15. Alkemade A, Friesema EC, Kuiper GG, Wiersinga WM, Swaab DF, Visser TJ & Fliers E. Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary. European Journal of Endocrinology 2006 154 491-500. (doi:10.1530/eje.1.02111)
16. Alkemade A, Friesema EC, Kalsbeek A, Swaab DF, Visser TJ & Fliers E. Expression of thyroid hormone transporters in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 2011 96 E967-E971. (doi:10.1210/jc.2010-2750)
17. Yen PM, Ando S, Feng X, Liu Y, Maruvada P & Xia X. Thyroid hormone action at the cellular, genomic and target gene levels. Molecular and Cellular Endocrinology 2006 246 121-127. (doi:10.1016/j.mce.2005.11.030)
18. Gereben B, Zeold A, Dentice M, Salvatore D & Bianco AC. Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cellular and Molecular Life Sciences 2008 65 570-590. (doi:10.1007/s00018-007-7396-0)
19. Burmeister LA, Pachucki J & St Germain DL. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both preand posttranslational mechanisms. Endocrinology 1997 138 5231-5237.
20. Riskind PN, Kolodny JM & Larsen PR. The regional hypothalamic distribution of type II 5' -monodeiodinase in euthyroid and hypothyroid rats. Brain Research 1987 420 194-198. (doi:10.1016/0006-8993(87)90260-5)
21. Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL, Wiersinga WM, Swaab DF, Visser TJ & Fliers E. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 2005 90 4322-4334. (doi:10.1210/jc.2004-2567)
22. Fliers E, Alkemade A, Wiersinga WM & Swaab DF. Hypothalamic thyroid hormone feedback in health and disease. Progress in Brain Research 2006 153 189-207.
23. Fliers E, Klieverik LP & Kalsbeek A. Novel neural pathways for metabolic effects of thyroid hormone. Trends in Endocrinology and Metabolism 2010 21 230-236. (doi:10.1016/j.tem.2009.11.008)
24. Sjogren M, Alkemade A, Mittag J, Nordstrom K, Katz A, Rozell B, Westerblad H, Arner A & Vennstrom B. Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor α1. EMBO Journal 2007 26 4535-4545. (doi:10.1038/sj.emboj.7601882)
25. Lopez M, Varela L, Vazquez MJ, Rodriguez-Cuenca S, Gonzalez CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nature Medicine 2010 16 1001-1008. (doi:10.1038/nm.2207)
26. Klieverik LP, Sauerwein HP, Ackermans MT, Boelen A, Kalsbeek A & Fliers E. Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. American Journal of Physiology. Endocrinology and Metabolism 2008 294 E513-E520. (doi:10.1152/ajpendo.00659.2007)
27. Klieverik LP, Janssen SF, van Riel A, Foppen E, Bisschop PH, Serlie MJ, Boelen A, Ackermans MT, Sauerwein HP, Fliers E et al. Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver. PNAS 2009 106 5966-5971. (doi:10.1073/pnas.0805355106)
28. Mittag J, Lyons DJ, Sällström J, Vujovic M, Dudazy-Gralla S, Warner A, Wallis K, Alkemade A, Nordström K, Monyer H et al. Thyroid hormone is required for hypothalamic neurons regulating cardiovascular functions. Journal of Clinical Investigation 2013 123 509-516. (doi:10.1172/JCI65252)
29. Varela L, Martínez-Sánchez N, Gallego R, Vázquez MJ, Roa J, Gándara M, Schoenmakers E, Nogueiras R, Chatterjee K, Tena-Sempere M et al. Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism. Journal of Pathology 2012 227 209-222. (doi:10.1002/path.3984)
30. Fliers E, Unmehopa UA & Alkemade A. Functional neuroanatomy of thyroid hormone feedback in the human hypothalamus and pituitary gland. Molecular and Cellular Endocrinology 2006 251 1-8. (doi:10.1016/j.mce.2006.03.042)
31. Fekete C & Lechan RM. Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. Endocrine Reviews 2013 35 159-194. (doi:10.1210/er.2013-1087)
32. Fuzesi T, Wittmann G, Lechan RM, Liposits Z & Fekete C. Noradrenergic innervation of hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in rats. Brain Research 2009 1294 38-44. (doi:10.1016/j.brainres.2009.07.094)
33. Perello M, Stuart RC & Nillni EA. The role of intracerebroventricular administration of leptin in the stimulation of prothyrotropin releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology 2006 147 3296-3306. (doi:10.1210/en.2005-1533)
34. Chiamolera MI & Wondisford FE. Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 2009 150 1091-1096. (doi:10.1210/en.2008-1795)
35. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL & Galton VA. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Molecular Endocrinology 2001 15 2137-2148. (doi:10.1210/mend.15.12.0740)
36. Shupnik MA. Thyroid hormone suppression of pituitary hormone gene expression. Reviews in Endocrine & Metabolic Disorders 2000 1 35-42. (doi:10.1023/A:1010008318961)
37. Steel JH, Van Noorden S, Ballesta J, Gibson SJ, Ghatei MA, Burrin J, Leonhardt U, Domin J, Bloom SR & Polak JM. Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors. Endocrinology 1988 122 270-282. (doi:10.1210/endo-122-1-270)
38. Ortiga-Carvalho TM, Curty FH, Nascimento-Saba CC, Moura EG, Polak J & Pazos-Moura CC. Pituitary neuromedin B content in experimental fasting and diabetes mellitus and correlation with thyrotropin secretion. Metabolism 1997 46 149-153. (doi:10.1016/S0026-0495(97)90293-6)
39. Sun Y, Bak B, Schoenmakers N, van Trotsenburg AS, Oostdijk W, Voshol P, Cambridge E, White JK, le Tissier P, Gharavy SN et al . Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nature Genetics 2012 44 1375-1381. (doi:10.1038/ng.2453)
40. Prummel MF, Brokken LJ, Meduri G, Misrahi M, Bakker O & Wiersinga WM. Expression of the thyroid-stimulating hormone receptor in the folliculo-stellate cells of the human anterior pituitary. Journal of Clinical Endocrinology and Metabolism 2000 85 4347-4353. (doi:10.1210/jcem.85.11.6991)
41. Scanlon MF, Toft AD. Regulation of thyrotropin secretion. In: The Thyroid, 8th Ed, pp 234-253. Eds LE Braverman & RD Utiger. Philadelphia, PA, USA: Lippincott 2005.
42. 3 in euthyroid humans. Journal of Clinical Investigation 2005 115 2524-2533. (doi:10.1172/JCI25083)
43. Schneider MJ, Fiering SN, Thai B, Wu SY, St Germain E, Parlow AF, St Germain DL & Galton VA. Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 2006 147 580-589. (doi:10.1210/en.2005-0739)
44. Jakobs TC, Schmutzler C, Meissner J & Kohrle J. The promoter of the human type I 5' -deiodinase gene - mapping of the transcription start site and identification of a DR+4 thyroid-hormone-responsive element. European Journal of Biochemistry 1997 247 288-297. (doi:10.1111/j.1432-1033.1997.00288.x)
45. Toyoda N, Zavacki AM, Maia AL, Harney JW & Larsen PR. A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Molecular and Cellular Biology 1995 15 5100-5112.
46. Peeters RP, van der Deure WM& Visser TJ. Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. European Journal of Endocrinology 2006 155 655-662. (doi:10.1530/eje.1.02279)
47. Peeters RP, van den Beld AW, Attalki H, Toor H, de Rijke YB, Kuiper GG, Lamberts SW, Janssen JA, Uitterlinden AG & Visser TJ. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. American Journal of Physiology. Endocrinology and Metabolism 2005 289 E75-E81. (doi:10.1152/ajpendo.00571.2004)
48. Canani LH, Capp C, Dora JM, Meyer EL, Wagner MS, Harney JW, Larsen PR, Gross JL, Bianco AC & Maia AL. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2005 90 3472-3478. (doi:10.1210/jc.2004-1977)
49. Heemstra KA, Hoftijzer H, van der Deure WM, Peeters RP, Hamdy NA, Pereira A, Corssmit EP, Romijn JA, Visser TJ & Smit JW. The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turnover and decreased femoral neck bone mineral density. Journal of Bone and Mineral Research 2010 25 1385-1391. (doi:10.1002/jbmr.27)
50. Aranda A & Pascual A. Nuclear hormone receptors and gene expression. Physiological Reviews 2001 81 1269-1304.
51. Bassett JH, Harvey CB &Williams GR. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Molecular and Cellular Endocrinology 2003 213 1-11. (doi:10.1016/j.mce.2003.10.033)
52. Wood WM, Dowding JM, Haugen BR, Bright TM, Gordon DF & Ridgway EC. Structural and functional characterization of the genomic locus encoding the murine β2 thyroid hormone receptor. Molecular Endocrinology 1994 8 1605-1617.
53. Liu RT, Suzuki S, Miyamoto T, Takeda T, Ozata M & DeGroot LJ. The dominant negative effect of thyroid hormone receptor splicing variant α2 does not require binding to a thyroid response element. Molecular Endocrinology 1995 9 86-95.
54. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiological Reviews 2001 81 1097-1142.
55. Stoykov I, Zandieh-Doulabi B, Moorman AF, Christoffels V, Wiersinga WM & Bakker O. Expression pattern and ontogenesis of thyroid hormone receptor isoforms in the mouse heart. Journal of Endocrinology 2006 189 231-245. (doi:10.1677/joe.1.06282)
56. Cheng SY, Leonard JL & Davis PJ. Molecular aspects of thyroid hormone actions. Endocrine Reviews 2010 31 139-170. (doi:10.1210/er.2009-0007)
57. Refetoff S & Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Practice & Research. Clinical Endocrinology & Metabolism 2007 21 277-305. (doi:10.1016/j.beem.2007.03.005)
58. Ferrara AM, Onigata K, Ercan O, Woodhead H, Weiss RE & Refetoff S. Homozygous thyroid hormone receptor b-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. Journal of Clinical Endocrinology and Metabolism 2012 97 1328-1336. (doi:10.1210/jc.2011-2642)
59. Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, Henning E, Reinemund J, Gevers E, Sarri M et al. A mutation in the thyroid hormone receptor a gene. New England Journal of Medicine 2012 366 243-249. (doi:10.1056/NEJMoa1110296)
60. van Mullem A, van Heerebeek R, Chrysis D, Visser E, Medici M, Andrikoula M, Tsatsoulis A, Peeters R & Visser TJ. Clinical phenotype and mutant TRa 1. New England Journal of Medicine 2012 366 1451-1453. (doi:10.1056/NEJMc1113940)
61. Brabant G, Prank K, Ranft U, Schuermeyer T, Wagner TO, Hauser H, Kummer B, Feistner H, Hesch RD & von zur Mühlen A. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. Journal of Clinical Endocrinology and Metabolism 1990 70 403-409. (doi:10.1210/jcem-70-2-403)
62. Allan JS & Czeisler CA. Persistence of the circadian thyrotropin rhythm under constant conditions and after light-induced shifts of circadian phase. Journal of Clinical Endocrinology and Metabolism 1994 79 508-512.
63. Kalsbeek A & Fliers E. Daily regulation of hormone profiles. Handbook of Experimental Pharmacology 2013 217 185-226.
64. Kalsbeek A, Fliers E, Franke AN, Wortel J & Buijs RM. Functional connections between the suprachiasmatic nucleus and the thyroid gland as revealed by lesioning and viral tracing techniques in the rat. Endocrinology 2000 141 3832-3841. (doi:10.1210/endo.141.10.7709)
65. Roelfsema F, Pijl H, Kok P, Endert E, Fliers E, Biermasz NR, Pereira AM & Veldhuis JD. Thyrotropin secretion in healthy subjects is robust and independent of age and gender, and only weakly dependent on body mass index. Journal of Clinical Endocrinology and Metabolism 2013 99570-578. (doi:10.1210/jc.2013-2858)
66. Legradi G, Emerson CH, Ahima RS, Flier JS & Lechan RM. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997 138 2569-2576.
67. Diano S, Naftolin F, Goglia F & Horvath TL. Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus. Endocrinology 1998 139 2879-2884.
68. Rondeel JM, Heide R, de Greef WJ, van Toor H, van Haasteren GA, Klootwijk W & Visser TJ. Effect of starvation and subsequent refeeding on thyroid function and release of hypothalamic thyrotropin-releasing hormone. Neuroendocrinology 1992 56 348-353. (doi:10.1159/000126248)
69. Boelen A, van Beeren M, Vos X, Surovtseva O, Belegri E, Saaltink DJ, Vreugdenhil E, Kalsbeek A, Kwakkel J & Fliers E. Leptin administration restores the fasting-induced increase of hepatic type 3 deiodinase expression in mice. Thyroid 2012 22 192-199. (doi:10.1089/thy.2011.0289)
70. Vella KR, Ramadoss P, Lam FS, Harris JC, Ye FD, Same PD, O'Neill NF, Maratos-Flier E & Hollenberg AN. NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways. Cell Metabolism 2011 14 780-790. (doi:10.1016/j.cmet.2011.10.009)
71. Boelen A, Wiersinga WM & Fliers E. Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid 2008 18 123-129. (doi:10.1089/thy.2007.0253)
72. Boelen A, Kwakkel J & Fliers E. Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocrine Reviews 2011 32 670-693. (doi:10.1210/er.2011-0007)
73. Boelen A, Platvoet-ter Schiphorst MC & Wiersinga WM. Association between serum interleukin-6 and serum 3,5,3 0 -triiodothyronine in nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 1993 77 1695-1699.
74. Hashimoto H, Igarashi N, Yachie A, Miyawaki T & Sato T. The relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection. Journal of Clinical Endocrinology and Metabolism 1994 78 288-291.
75. Raja SG & Berg GA. Outcomes of off-pump coronary artery bypass surgery: current best available evidence. Indian Heart Journal 2007 59 15-27.
76. Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E & Wiersinga WM. Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. Journal of Endocrinology 2004 182 315-323. (doi:10.1677/joe.0.1820315)
77. Fekete C, Gereben B, Doleschall M, Harney JW, Dora JM, Bianco AC, Sarkar S, Liposits Z, Rand W, Emerson C et al. Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology 2004 145 1649-1655. (doi:10.1210/en.2003-1439)
78. Palsson-McDermott EM & O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004 113 153-162. (doi:10.1111/j.1365-2567.2004.01976.x)
79. Boelen A, Kwakkel J, Alkemade A, Renckens R, Kaptein E, Kuiper G, Wiersinga WM & Visser TJ. Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology 2005 146 5128-5134. (doi:10.1210/en.2005-0608)
80. Kwakkel J, Surovtseva OV, de Vries EM, Stap J, Fliers E & Boelen A. A novel role for the thyroid hormone-activating enzyme type 2 deiodinase in the inflammatory response of macrophages. Endocrinology 2014 155 2725-2734. (doi:10.1210/en.2013-2066)
81. Angelousi AG, Karageorgopoulos DE, Kapaskelis AM & Falagas ME. Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock: a systematic review. European Journal of Endocrinology 2011 164 147-155. (doi:10.1530/EJE-10-0695)
82. Van den Berghe G, De Zegher F, Veldhuis JD, Wouters P, Gouwy S, Stockman W, Weekers F, Schetz M, Lauwers P, Bouillon R et al. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormonesecretagogues. Clinical Endocrinology 1997 47 599-612. (doi:10.1046/j.1365-2265.1997.3371118.x)
83. Fliers E, Guldenaar SEF, Wiersinga WM & Swaab DF. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 1997 82 4032-4036.
84. Peeters RP, van der Geyten S, Wouters PJ, Darras VM, van Toor H, Kaptein E, Visser TJ & Van den Berghe G. Tissue thyroid hormone levels in critical illness. Journal of Clinical Endocrinology and Metabolism 2005 90 6498-6507. (doi:10.1210/jc.2005-1013)
85. Peeters RP, Wouters PJ, Kaptein E, Van Toor H, Visser TJ & Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. Journal of Clinical Endocrinology and Metabolism 2003 88 3202-3211. (doi:10.1210/jc.2002-022013)
86. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. European Journal of Endocrinology 2000 143 1-13. (doi:10.1530/eje.0.1430001)
87. Arem R, Wiener GJ, Kaplan SG, Kim HS, Reichlin S & Kaplan MM. Reduced tissue thyroid hormone levels in fatal illness. Metabolism 1993 42 1102-1108. (doi:10.1016/0026-0495(93)90266-Q)
88. Weekers F, Van Herck E, Coopmans W, Michalaki M, Bowers CY, Veldhuis JD & Van den Berghe G. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology 2002 143 764-774. (doi:10.1210/endo.143.3.8664)